Today Sponge
This article was originally published in The Tan Sheet
Executive Summary
Allendale Pharmaceuticals retains additional manufacturing site for export-only production of contraceptive device. Firm continues to work toward use of Accupac manufacturing plant in Mainland, Penn., although GMP issues at that site have delayed FDA approval of the Sponge. Second, unidentified facility has "impeccable GMP record," says Allendale, which is trying to raise $300,000-$500,000 in private investment to offset depleted funds from approval delays